baber/WOPTO huggingface dataset:
Patent NZ-334074-A (NZ)
Title: Friction joint for latch of a window sash or sliding door
Inventor: GOLSBURY AARON
IPC: E05B65/00
Filed: 1999-02-04
Abstract: A single point fastener for latching a window or a door in a closed position is disclosed.  A friction joint coupling comprising of a base (10) and a latch body (19) such that relative rotational movement can occur between them, the coupling being achieved by a headed fastening means (28).  The friction joint includes a sleeve (27) to which an end load is applied upon an axial movement of the fastening means (28) taking place during coupling of the base (10) and the latch body (19), such end load causing the sleeve (27) to collapse.  The full latched and full release position of the hook shaped latch element (20) is governed by the movement of the projection (22) in the channel (17).   The projection (22) on the upper flat surface engages in a curved groove (36) in the opposite surface of the disc element (23).
Patent NZ-335205-A (NZ)
Title: Garage door opener motor has triac in main winding circuit, relays in starting circuit
Inventor: CRIMMINS TERENCE
IPC: E05F15/16
Filed: 1999-04-14
Abstract: This control circuit for the motor of a door operator, for example a garage door opener includes an AC motor 14, with starting winding 53.  The starting winding is connected by relays 36 and 37, which control the motor direction.  The starting winding may be cut out by a centrifugal switch, or by a motor speed sensor.  Motor speed may be measured by measuring the speed of the door limit shaft.  The power to the main motor winding 51 is controlled by triac 38.  The control unit may contain a microprocessor for controlling the function of the opener.
Patent NZ-336379-A (NZ)
Title: Nitric oxide synthase inhibitor, use and process of preparation
Inventor: BEAMS RICHARD MANSFIELD
IPC: A61P11/08
Filed: 1998-01-09
Abstract: Provided a compound of formula (I) or a salt, solvate, or physiologically functional derivative thereof. Formula (I) includes an asymmetric centre in the amino acid group, and although the natural L or (S) configuration of arginine is preferred, it is intended that formula (I) includes both (S) and (R) enantiomers either in substantially pure form or admixed in any proportions. Specifically described are: (R/S)-[2-(1 -iminoethylamino)ethyl]-DL-homocysteine (S)-[2-(1-iminoethylamino) ethyl]-L-homocysteine; and (R)-[2-(1 -iminoethylamino)ethyl]-D-homocysteine and salts, solvates, and physiologically functional derivatives thereof. Salts and solvates of compounds of formula (I) which are suitable for use in treating clinical conditions such as arthritis, asthma, ileus and migraine are those wherein the counterion or associated solvent is pharmaceutically acceptable. S Salts and solvates having non-pharmaceutically acceptable counterions or associated solvents are useful as intermediates in the preparation of other compounds of formula (I) and their pharmaceutically acceptable salts, solvates, and physiologically functional derivatives.
Patent NZ-501477-A (NZ)
Title: Smoking material containing an inorganic filler, binder and a non-polyol aerosol generator and a smoking article thereof
Inventor: BIGGS PHILIP JOHN
IPC: A24B15/16
Filed: 1998-05-29
Abstract: A smoking material comprises a non-polyol aerosol generator, tobacco with the tobacco being present in the amount of no more than 20% by weight, binder at not more than 20% by weight and not less than 30% by weight of inorganic filler.  The non-polyol aerosol generator is one or more of triethylene glycol diacetate, glycerol triacetate or glycerol diacetate. Also disclosed is a smoking material comprising a non-polyol aerosol generator with the total amount of the non-polyol aerosol generator being 30% or less by weight, no tobacco, binder at less than 10% by weight and not less than 30% by weight of inorganic filler. A smoking article comprises a filter and a smokeable rod comprising a core and an outer part.  The core comprises a first particulate smoking material and a first cigarette paper wrapper enwrapping the first smoking material.  The outer part comprises a second particulate smoking material disposed annularly about the core and a second cigarette paper wrapping enwrapping the second smoking material.  The first and/or smoking material comprises the smoking material as defined above.
Patent NZ-505761-A (NZ)
Title: Method for treating alzheimer's disease using plasma-triglceride level-lowering agents or agents that interfer with cholesterol ester synthesis
Inventor: BISGAIER CHARLES LARRY
IPC: A61K31/22
Filed: 1998-12-02
Abstract: A compound of formula (I) wherein: n and m are integers from 2 to 9; R1, R2, R3, and R4 independently are C1-C6alkyl, C2-C6alkenyl, C2-C6 alkynyl, and R1 and R2 together with the carbon to which they are attached, and R3 and R4 together with the carbon to which they are attached, can complete a carbocyclic ring having from 3 to 6 carbons; Y1 and Y2 independently are COOH, CHO, tetrazole, and COOR5 where R5 is C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl; and where the alkyl, alkenyl, and alkynyl groups may be substituted with one or two groups selected from halo, hydroxy, C1-C6 alkoxy, and phenyl; or the compound of formula (II) can used in the manufacture of a medicaments for treating Alzheimer's Disease. The compounds can also be used in combination with a plasma cholesterol level lowering agent Also described is the use of agent that interferes with cholesterol ester synthesis in the manufacture of a medicament for treating Alzheimer's Disease. Preferably the agent is the ACAT inhibitor of formula (III) wherein X and Y are oxygen, sulfur or (CR'R'')n wherein n is 1 to 4; R is hydrogen, alkyl or benzyl and R1 and R2 are aryl and cycloalkyl. The compound can also be used in combination with a plasma cholesterol lowering agent.
Patent NZ-509591-A (NZ)
Title: Light-colored rosin esters and adhesive compositions
Inventor: FRIHART CHARLES R
IPC: C09J193/04
Filed: 1999-07-27
Abstract: Rosin esters that are both light-coloured and colour stable may be produced by reacting rosin with an organic compound containing two or more hydroxyl groups each separated from each other by at least four carbon atoms. With appropriate choices for the esterification catalyst and antioxidant(s), the rosin ester can be formulated into an adhesive composition. The adhesive compositions will further comprise an appropriate adhesive polymer.
Patent NZ-514359-A (NZ)
Title: Stabiliser tool block wear pad assembly
Inventor: BASSAL ADEL ALI
IPC: E21B17/10
Filed: 2000-03-23
Abstract: The present apparatus is for a drill string stabiliser tool  (18)  used in borehole drilling. The tool  includes  a symmetrical body (20) with a plurality of external  recesses (22).  The  recesses  (22) have internal  opposite  surfaces (23)  that converge inwardly from the outer surface  of  the body.  A  pad assembly (24) is disposed in each recess  (22) and  includes  a  wedge block (28) with converging  radially inwardly   opposite   side  surface   (29)   complementarily abutting said recess surfaces. Each wedge block (28)  has  a bolt  (30) securing said wedge block (28) to said body  (20) and  is  slightly larger dimensioned than the  recess  (22). The  angles  of  the wedge blocks and the  recesses  are  so chosen to effect an interference fit so that when the  wedge block  (28)  is forced into the recess (22) by  use  of  the bolt (30) it is held there by an interference fit.
Patent NZ-516571-A (NZ)
Title: Resealable packaging wherein a slider is positioned to open and close the interlocking members which is further enclosed with a fragile tear strip to provide access for the user to the slider
Inventor: SCHNEIDER JOHN H
IPC: B65D65/26
Filed: 2002-01-11
Abstract: A reclosable, tamper-evident package with a first wall and a second wall opposite to the first wall.  A first zipper profile including a first interlocking member is attached to the first wall and a second profile having a second interlocking member, engagable with the first interlocking member, is attached to the second wall.  A slider is positioned on the profiles for movement from side to side of the package.  Package material is provided which must be removed or ruptured to permit operation of the slider or to provide access to the package contents.  In either event, the steps needed to permit the initial access to the package contents leave clear evidence for a consumer that the package has been opened.
Patent NZ-523247-A (NZ)
Title: Use of the teleost alevin system for the screening of antiarrythmic drugs
Inventor: LENGHEINRICH ULRIKE
IPC: G01N33/15
Filed: 2001-05-19
Abstract: Described is a method for the identification of agents influencing cardiovascular function utilising teleost alevin. The method is also applicable for the identification of genes regulating heart function. The figure shows the effects of cardiac pharmaceutical (at a concentration of 100 ìM) on the heart beat rate of 2-day old zebrafish larvae.
Patent NZ-523479-A (NZ)
Title: Method for the production of imidazo-[1,2-c][2,3]-benzodiazepines and intermediates in the production thereof
Inventor: WINTER ERIC
IPC: C07D243/00
Filed: 2001-07-26
Abstract: Disclosed is a process for the production of imidazo[1,2-c][2,3]benzodiazepines of general formula 1as defined in the specification by esterification of a compound of general formula 4 followed by condensation with ammonia to a compound of formula 6. The compound of formula 6 is converted to a compound of formula 1 by way of hydrazinolysis. Also disclosed are phenylacetic acid esters of general formula 5 and oxazole derivatives of formula 6 as intermediates in the process described.
Patent NZ-523529-A (NZ)
Title: Recycled material and mixing machinery for backfilling roads
Inventor: OWEN FRANK
IPC: B09B3/00
Filed: 2001-07-09
Abstract: Site-won spoil from an excavation which is a predominantly non-granular cohesive material can be converted into a material suitable for immediate use as a backfill material by a process of mechanically mixing the spoil with between 0 and 30 % by weight or volume of added granular material and between 1 and 10 % by weight or volume of a powder material comprising 1-5 % lime or with the addition of 1-5 % cement and/or 1-5 % pulverised fly ash. The process works well with clay soils and adding cement to the powder material can extend the range of suitable spoil. The proportions in the mixture are chosen in dependence on the clay and moisture content of the spoil. A machine, which can be set to mix the ingredients and water in the correct proportions on site, is also described.
Patent NZ-525306-A (NZ)
Title: Spray drying process and compositions of fenofibrate
Inventor: PACE GARY
IPC: A61K31/365
Filed: 2001-04-20
Abstract: Spray drying process for the preparation of pharmaceutical compositions containing small particles of phospholipid-stabilized fenofibrate is disclosed. The spray dried powdered compositions prepared according to this process and the dosage forms of fenofibrate (capsules, tablets, powders, granules, and dispersions) prepared from these powdered compositions is also disclosed. These powdered compositions and dosage forms are useful in the treatment of dyslipidemia and dyslipoproteinemia and have the advantage that they provide reduced in vivo variability in the bioavailability of fenofibrate active species among fed and fasted patients when administered orally.
Patent NZ-525536-A (NZ)
Title: Treatment of arthritis and other similar conditions
Inventor: HULL PETER HUGH
IPC: A61P19/02
Filed: 2002-02-26
Abstract: The use of ngali nut oil or an extract thereof in the manufacture of a medicament for the treatment of the manifestations of arthritis and other similar conditions. (62) Divided out of 507764
Patent NZ-529428-A (NZ)
Title: Graphics transfers for use in rotational molding
Inventor: STEVENSON MICHAEL J
IPC: B29C41/06
Filed: 2002-05-17
Abstract: This invention is an indicia transfer and method for its use to impart indicia to polylefin objects during rotational molding. The transfer is a laminating of at least three coats on a carrier sheet, which is preferably a flexible, transparent polymer sheet. The coats, as successive layers on the carrier sheet are: a backing coat of a first pressure sensitive adhesive, an indicia coat of a colorant in a graphic or alphanumerical array, and a top coat of a second pressure sensitive adhesive. The pressure sensitive adhesive used for the backing coat has a transition temperature greater than the surface temperature of the mold to which the transfer is to be applied while the pressure sensitive adhesive used for the top coat has a transition temperature less than the mold surface temperature to enable transfer of the coats to the interior surface of a rotational mold.
Patent NZ-534074-A (NZ)
Title: Combined chainsaw and shears pruning device with grippable arms articulating perpendicular to a pivot axis
Inventor: STONES KEVIN
IPC: A01G3/08
Filed: 2004-07-13
Abstract: A vegetation pruning device 2 comprises a pair of arms 4, 6 adapted to pivot relative to each other about an axis to adjust the angle between them. The device also includes a motor having a rotary output drive and an endless flexible cutting element 8 mounted to a first arm, which is driven by the rotary output drive. The arms are adapted to be gripped by a user at a pair of the handle portions oriented substantially symmetrically relative to each other about the axis, so as to articulate perpendicular to the pivot axis.
Patent NZ-537251-A (NZ)
Title: Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
Inventor: CHENG PETER T W
IPC: A61K31/50
Filed: 2003-07-08
Abstract: Disclosed are compounds of formula (I) wherein the substituents are as described in the specification. Compounds of the type disclosed are useful for treating diabetes or type 2 diabetes.
Patent NZ-538159-A (NZ)
Title: A method of immunomodulation using antibodies associating with CD83
Inventor: KATO MASATO
IPC: C07K16/28
Filed: 2003-08-15
Abstract: A method is described for modulating the activity of cells of the immune system using CD83 specific antibodies, which interact specifically with epitopes present on the surface of antigen-presenting cells and lymphocytes in vivo or in vitro. The antibody binding with CD83 induces lysis of myeloid dendrite cells and T cells. Further included is a method of using such antibodies, wherein the antibody is conjugated with a toxic component which induces or otherwise facilitates lysis of the APC and/or lymphocytes. A practical application is using such antibodies to reduce or suppress immune rejection of an immune-competent graft or bone marrow graft after transplantation. The antibodies may be useful to modulate immunological activity of stimulator and responder cells in a range of immuno-therapeutic and immuno-prophylactic treatments that benefit from immune suppression.
Patent NZ-540583-A (NZ)
Title: Juice recovery process
Inventor: LANG TIMOTHY RALSTON
IPC: C12G1/00
Filed: 2003-08-28
Abstract: Processes and apparatus for processing plant material residue remaining after primary juice has been extracted from the plant material are described. In one implementation the process comprises using a diffusion extractor to extract a liquid portion from the plant material residue. The liquid portion is then fractioned using a number of fractioning devices to produce secondary juice. The secondary juice is then added to the primary juice.
Patent NZ-541190-A (NZ)
Title: Process for the preparation of diphenic acid
Inventor: TIWARI KAUSHAL KISHORE
Filed: 2002-12-23
Abstract: A process for the preparation of diphenic acid from phenanthrene which comprises (i) heating phenanthrene and glacial acetic acid, at a temperature in a range of 75 Deg C to 85 Deg C, (ii) adding drop-wise a pre-determined amount of 30% hydrogen peroxide, over a period of from 30 to 60 minutes to form a resulting mixture, (iii) heating the resulting mixture for 3 to 7 hours after completion of drop-wise addition of hydrogen peroxide, (iv) distilling the resulting mixture under reduced pressure to make the volume half, (v) cooling the mixture until diphenic acid crystallizes out, (vi) filtering the cooled mixture to form a residue and a filtrate, and boiling the residue after adding 10% solution of sodium carbonate and activated charcoal, (vii) filtering and discarding the residue; (viii) acidifying the filtrate with hydrogen chloride to form a resultant mixture; (ix) cooling the resultant mixture until more diphenic acid crystallizes out; and (x) repeating filtration until pure diphenic acid is obtained.
Patent NZ-546369-A (NZ)
Title: Antibodies to M-CSF
Inventor: BEDIAN VAHE
IPC: G06Q30/00
Filed: 2004-09-09
Abstract: Provided is a human monoclonal antibody or an antigen-binding portion thereof that specifically binds to M-CSF, wherein the antibody or portion comprises: a) a heavy chain comprising the heavy chain CDR1, CDR2 and CDR3 of an antibody 8.10.3F, 8.10.3 (ATCC Hybridoma Accession No. PTA-5395), 8.1 0.3C-Ser, 8.10.3-CG2, 8.1 0.3-Ser, 8.10.3CG4, or 8.10.3FG1; or b) the heavy chain of a) and a light chain comprising the light chain CDR1, CDR2 and CDR3 of the selected antibody. Further provided is the use of the compositions for the manufacture of a medicament to treat arthritis, asthma, cancer, inflammatory conditions and various other diseases.
Patent NZ-547317-A (NZ)
Title: Method for producing formaldehyde
Inventor: OLBERT GERHARD
IPC: F28D9/00
Filed: 2004-12-23
Abstract: A method for the production of formaldehyde by gas phase oxidation of methanol vapour with a gas flow containing a molecular oxygen in the presence of solid bed catalyst containing iron and molybdenum is carried out in a reactor (1) comprising thermal sheet metal plates (2) which are arranged in the longitudinal direction of the reactor (1) and spaced from each other. A heat transfer medium flows through the gaps between the plates. The heat transfer medium is transferred via inlets and outlets 3, 4 to the thermal sheet steel plates (2), and gaps (5) between the thermal sheet steel metal plates (2) and which are filled with the solid bed catalyst and into which the gas containing the methanol vapour and the molecular oxygen flows.
Patent NZ-551436-A (NZ)
Title: Dispensing device containing soluble substance released by dissolving in urine stream, typically of cow
Inventor: QUIN BERTRAM FRANCIS CHARLES
Filed: 2006-11-21
Abstract: A dispensing device consists of a carrier holding a soluble substance, typically a urea inhibitor, which is capable of being presented to a urine stream, typically that of a cow, such that the soluble substance is released by being dissolved in the stream.
Patent NZ-553474-A (NZ)
Title: Pipe section provided with a socket end part having varying length and angle of taper around circumference
Inventor: SNIJDERS JOHANNES HENDRIKUS GERHARDUS
IPC: F16L21/035
Filed: 2005-08-10
Abstract: With a pipe section provided with a socket end part (1) which is intended for accommodating a spigot end part (2) of a second pipe section, the exterior of the spigot end part is provided with a sealing ring (5), the interior of the socket end part (1) has a part (13) obliquely tapering towards the centre axis (12) of the socket end part for deforming the sealing ring (5) when the spigot end part (2) and an adjoining cylindrical part (14) are inserted into the socket end part (1). The obliquely tapering part (13) has at least two areas (15) distributed regularly over the circumference in which the angle of the obliquely tapering part (13) varies relative to the centre axis (12) of the socket end- part in the circumferential direction.
Patent NZ-555155-A (NZ)
Title: Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome
Inventor: KADEREIT DIETER
IPC: A61K31/215
Filed: 2005-11-30
Abstract: Disclosed is the use of compound of formula I, or a pharmaceutically acceptable salt thereof, wherein R1 is H, R2 is optionally substituted alkyl, alkenyl, or alkynyl, and R3, R4, R5, and R6 are each H, F, or (C1-C4)-alkyl, for treating metabolic syndrome, or for treating a disease or disorder which results in increased levels of plasma lipid, plasma free fatty acids, plasma glycerol, or plasma triglyceride, or for treating type 2 diabetes or diabetic dyslipidemia.
Patent NZ-555167-A (NZ)
Title: Anthranilamide derivatives as insecticides
Inventor: JEANGUENAT ANDRE
IPC: C07D401/04
Filed: 2005-12-07
Abstract: Disclosed is an anthranilamide derivative of formula I where the substituents are as described in the specification. The compound is useful as an insecticide, particularly for the control of members of the order Acarina.
Patent NZ-555989-A (NZ)
Title: Compositions comprising an epothilone, hydroxyalkyl-beta-cyclodextrin and an excipient, and production methods
Inventor: REER OLAF
IPC: A61K9/00
Filed: 2005-12-20
Abstract: Disclosed is a method of producing a composition comprising the steps of (a) dissolving (1S, 3S, 7S, 10R, 11S, 12S, 16R)-7,11-dihydroxy-3-(2-methyl-benzothiazol-5-yl)-10-(prop-2-en-1-yl)-8,8, 12,16-tetramethyl-4,17-dioxabicyclo[14,1,0]heptadecane-5,9-dione in an organic solvent; b) dissolving hydroxyalkyl-beta-cyclodextrin in aqueous solution, together with at least one further pharmaceutically acceptable excipient; optionally c) adjusting the pH of the resulting mixture of b) to a pH ranging between 5 and 9 using an inorganic acid; d) mixing the resulting solvents a) and b) or a) and c); optionally e) carrying out sterile filtering of d) to achieve an original solution; and f) drying the original solution so as to remove the solvent resulting in a solid composition. A composition obtained by using the above method is also disclosed. Also disclosed is a composition comprising (1S, 3S, 7S, 10R, 11S, 12S, 16R)-7,11-dihydroxy-3-(2-methyl-benzothiazol-5-yl)-10-(prop-2-en-1-yl)-8,8, 12,16-tetramethyl-4,17-dioxabicyclo[14,1,0]heptadecane-5,9-dione, hydroxyalkyl-beta-cyclodextrin and at least one pharmaceutically acceptable excipient. The use of this composition for the manufacture of a medicament for the treatment of cancer is also disclosed.
Patent NZ-562881-A (NZ)
Title: High titer recombinant AAV production
IPC: C12N5/02
Filed: 2003-09-23
Abstract: Disclosed is a method for producing high titer recombinant adeno-associated virus (rAAV) comprising in vitro: (a) simultaneously co-infecting a mammalian cell with: (i) a first replication defective recombinant herpes simplex virus (rHSV) comprising a nucleic acid molecule encoding an AAV rep and an AAV cap gene, each operably linked to a promoter; and (ii) a second replication defective rHSV comprising rAAV internal terminal repeat (ITR) nucleic acid segments encoding AAV ITRs, a gene of interest, and a promoter operably linked to said gene; (b) incubating the cell; and (c) collecting rAAV produced from said mammalian cell, wherein the titer is up to at least 2160-4200 infectious rAAV particles per cell.
Patent NZ-566312-A (NZ)
Title: Microbubble washing composition comprising a protease and a lipase, microbubble washing method, and microbubble washing apparatus
Inventor: MIYAZAKI KAZUO
IPC: A61K33/10
Filed: 2008-02-28
Abstract: A microbubble washing method for washing a human body or an animal is disclosed, wherein the method comprises washing a human body or an animal using microbubbles and a washing liquid composition consisting essentially of at least one protease, at least one lipase and at least one alkali metal salt selected from the group consisting of the alkali metal carbonates, the alkali metal hydrogen carbonates, the alkali metal sulfates, the alkali halides, and the alkali metal salts of boron. Also described in a microbubble washing composition for washing a human body or an animal, a microbubble washing method using the microbubble washing composition, and a microbubble washing apparatus suitable for carrying out the method which are capable of safely removing sebum and old keratin adhering to the surfaces of the pores in a short period of time, keeping the skin clean for a long period of time, and preventing an odour.